• In mid-March 2026, Synopsys used NVIDIA’s GTC conference to highlight new AI-optimized chip design tools, expanded hardware-assisted verification platforms, and the early integration of Ansys simulation capabilities across silicon-to-systems workflows.
• The company’s work with NVIDIA, Applied Materials, Honda, Astera Labs, and ADI underscores Synopsys’ growing role at the center of GPU-accelerated engineering, physics-grounded simulation, and agentic AI for complex physical AI systems.
• Next, we’ll examine how Synopsys’ agentic AI design workflows unveiled at GTC 2026 could influence its existing investment narrative.

Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Synopsys Investment Narrative Recap

To own Synopsys, you need to believe it will remain a core enabler of increasingly complex AI chips and physical AI systems, while successfully integrating Ansys and protecting margins. The GTC announcements reinforce that role in GPU accelerated design, but they do not materially change the near term picture, where Ansys integration execution and cost discipline still look like the key catalyst, and integration risk around restructuring and higher financial complexity remains front and center.

Among the recent updates, the launch of Ansys 2026 R1 stands out as most connected to what Synopsys is showing at GTC. It is the first concrete wave of Synopsys Ansys workflow integration, linking chip level design, safety and materials insights into system aware engineering, and it ties directly into the core catalyst of expanding Synopsys’ reach from silicon into higher value, simulation heavy sectors like automotive and aerospace.

Yet investors should also be aware that the same Ansys integration that underpins this wider “silicon to systems” story brings higher debt, restructuring and...

Synopsys' narrative projects $12.1 billion revenue and $2.7 billion earnings by 2028. This requires 24.7% yearly revenue growth and roughly a $1.3 billion earnings increase from $1.4 billion today.

Uncover how Synopsys' forecasts yield a $537.75 fair value, a 26% upside to its current price.

Exploring Other Perspectives

Five fair value estimates from the Simply Wall St Community span roughly US$392 to US$538 per share, showing how differently individual investors view Synopsys’ potential. Against that backdrop, the success or missteps of the complex Ansys integration could heavily influence how those expectations line up with the company’s actual earnings power over time.

Explore 5 other fair value estimates on Synopsys - why the stock might be worth as much as 26% more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Synopsys research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Synopsys research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Synopsys' overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Our top stock finds are flying under the radar-for now. Get in early:

• We've uncovered the 15 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.